Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Chua

Showing results (81-90 of 380) with videos related to

Pageof 38
Sort By:
The Lancet. Oncology|June 8, 2023
Adjuvant chemotherapy in nasopharyngeal carcinomaPui Lam Yip, Anne W M Lee, Melvin L K Chua
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: <i>Quo Vadis</i>?Wai-Tong Ng, Melvin L K Chua, Anne W M Lee
Journal of Oral Rehabilitation|April 23, 2002
Clinical TMD, pain-related disability and psychological status of TMD patientsA U J Yap, E K Chua, J K E Hoe
Current Opinion in Oncology|March 6, 2026
Circulating Epstein-Barr virus DNA as a precision biomarker in nasopharyngeal carcinoma: from risk stratification to real-time treatment adaptation and disease surveillanceEmma R Y Zhang, Jia Ling Neo, Melvin L K Chua
JAMA Oncology|February 17, 2022
Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?Wai-Tong Ng, Melvin L K Chua, Anne W M Lee
Journal of Biomedical Materials Research. Part A|October 20, 2006
Compressive properties and degradability of poly(epsilon-caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradationK C Ang, K F Leong, C K Chua, et al.
The Lancet. Oncology|June 4, 2021
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinomaMelvin L K Chua, Wai-Tong Ng, Anne W M Lee
Med (New York, N.Y.)|January 10, 2026
DIAMOND in nasopharyngeal carcinoma: Time to drop cisplatin?Emma R Y Zhang, Ya Juan Zhou, Melvin L K Chua
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 20, 2003
Modulation of adhesion molecules and monocyte chemoattractant protein by tumor necrosis factor-alpha and salicylic acid in primary human coronary artery endothelial cellsP K Chua, R Yanagihara, M E Melish, et al.
Cell|May 30, 1997
The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAACJ A Berglund, K Chua, N Abovich, et al.
Pageof 38

Showing results (81-90 of 380) with videos related to

Sort By:
Pageof 38
The Lancet. Oncology|June 8, 2023
Adjuvant chemotherapy in nasopharyngeal carcinomaPui Lam Yip, Anne W M Lee, Melvin L K Chua
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: <i>Quo Vadis</i>?Wai-Tong Ng, Melvin L K Chua, Anne W M Lee
Journal of Oral Rehabilitation|April 23, 2002
Clinical TMD, pain-related disability and psychological status of TMD patientsA U J Yap, E K Chua, J K E Hoe
Current Opinion in Oncology|March 6, 2026
Circulating Epstein-Barr virus DNA as a precision biomarker in nasopharyngeal carcinoma: from risk stratification to real-time treatment adaptation and disease surveillanceEmma R Y Zhang, Jia Ling Neo, Melvin L K Chua
JAMA Oncology|February 17, 2022
Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?Wai-Tong Ng, Melvin L K Chua, Anne W M Lee
Journal of Biomedical Materials Research. Part A|October 20, 2006
Compressive properties and degradability of poly(epsilon-caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradationK C Ang, K F Leong, C K Chua, et al.
The Lancet. Oncology|June 4, 2021
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinomaMelvin L K Chua, Wai-Tong Ng, Anne W M Lee
Med (New York, N.Y.)|January 10, 2026
DIAMOND in nasopharyngeal carcinoma: Time to drop cisplatin?Emma R Y Zhang, Ya Juan Zhou, Melvin L K Chua
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 20, 2003
Modulation of adhesion molecules and monocyte chemoattractant protein by tumor necrosis factor-alpha and salicylic acid in primary human coronary artery endothelial cellsP K Chua, R Yanagihara, M E Melish, et al.
Cell|May 30, 1997
The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAACJ A Berglund, K Chua, N Abovich, et al.
Pageof 38